EBV-induced lymphoproliferative disease due to CD70 deficiency: A Patient Guide

CD70 deficiency is an ultra-rare, inherited immune disorder that leaves the body uniquely vulnerable to the Epstein-Barr Virus (EBV). In a healthy immune system, the CD70 protein acts as a critical communication bridge—a costimulatory signal—that helps activate the T cells responsible for finding and destroying cells infected with viruses like EBV. When this signaling pathway is impaired, the immune system can recognize the virus but struggles to launch an effective response, allowing EBV-infected cells to persist ^[1][2].

The condition follows a broad clinical spectrum, meaning the experience can vary significantly from one person to another. Some patients face severe, life-threatening complications, such as HLH (hemophagocytic lymphohistiocytosis) or lymphoma (blood cancer). Others may experience prolonged periods of stability with chronic viremia, where the virus remains detectable in their blood while they manage milder symptoms or recurrent infections ^[2][3]. Because the course is so individualized, care focuses on active surveillance and personalized medicine.

Living with CD70 deficiency involves three primary pillars of management: protection, monitoring, and potentially curative intervention. To help prevent common bacterial infections, some patients receive immunoglobulin replacement therapy, which provides the protective antibodies their own bodies may struggle to produce effectively ^[4][5]. Simultaneously, patients and medical teams must maintain an individualized schedule of EBV surveillance, using blood tests and careful clinical exams to monitor for signs of uncontrolled cell growth or hyperinflammation ^[2][6].

For some patients, a hematopoietic stem cell transplant (HSCT) may be considered. HSCT offers a potential way to replace the faulty immune system with healthy donor cells, theoretically curing the underlying immune defect ^[7][8]. However, transplant is not an inevitable path for everyone; it is a complex, high-risk procedure whose benefits, timing, and donor availability must be carefully assessed at an expert center. Through close coordination with a multidisciplinary medical team, the focus remains on empowering you or your child to manage the condition safely while navigating the uncertainties of a rare diagnosis.